The DOI matches its Crossref record; 129 of the 129 references it cites were found in a registry or an index.
Sickle cell disease: old discoveries, new concepts, and future promise
Open accessAbstract
The discovery of the molecular basis of sickle cell disease was an important landmark in molecular medicine. The modern tools of molecular and cellular biology have refined our understanding of its pathophysiology and facilitated the development of new therapies. In this review, we discuss some of the important advances in this field and the impediments that limit the impact of these advances.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Szer, J. (1999) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1999.tb127745.x · Cited by 3,353
Mortality in sickle cell disease. Life expectancy and risk factors for early death
Platt, O. S., Brambilla, D. J., Rosse, W. F., Milner, P. F., Castro, O., Steinberg, M. H., & Klug, P. P. (1994) · New England Journal of Medicine · doi:10.1056/nejm199406093302303 · Cited by 3,320
Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia
Charache, S., Terrin, M. L., Moore, R. D., Dover, G. J., Barton, F. B., Eckert, S. V., McMahon, R. P., & Bonds, D. R. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505183322001 · Cited by 2,340
Sickle Cell Anemia, a Molecular Disease
Pauling, L., Itano, H. A., Singer, S. J., & Wells, I. C. (1949) · Science · doi:10.1126/science.110.2865.543 · Cited by 2,319
Adams, R. J., McKie, V. C., Hsu, L., Files, B., Vichinsky, E., Pegelow, C., Abboud, M., Gallagher, D., Kutlar, A., Nichols, F. T., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807023390102 · Cited by 1,866
Cerebrovascular accidents in sickle cell disease: rates and risk factors.
(1998) · PubMed · doi:10.1182/blood.v91.1.288 · Cited by 1,694
Pain in Sickle Cell Disease: Rates and Risk Factors
Platt, O. S., Thorington, B. D., Brambilla, D. J., Milner, P. F., Rosse, W. F., Vichinsky, E., & Kinney, T. R. (1991) · New England Journal of Medicine · doi:10.1056/nejm199107043250103 · Cited by 1,546
Clegg, J. B., Naughton, M. A., & Weatherall, D. J. (1966) · Journal of Molecular Biology · doi:10.1016/s0022-2836(66)80052-9 · Cited by 1,482
Dams, R. O. J. A., Ie, V. I. C. M. C. K., Su, L. E. H., Iles, B. E. F., Ichinsky, E. L. V., Egelow, C. H. P., Bboud, M. I. A., Allagher, D. I. G., Utlar, K., Ichols, F. E. T. N., et al. (2015) · Cited by 1,338
Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease
Reiter, C. D., Wang, X., Tanus-Santos, J. E., Hogg, N., Cannon, R. O., Schechter, A. N., & Gladwin, M. T. (2002) · Nature Medicine · doi:10.1038/nm1202-799 · Cited by 1,330
Cited by
Circadian control of the immune system
Scheiermann, C., Kunisaki, Y., & Frenette, P. S. (2013) · Nature Reviews Immunology · doi:10.1038/nri3386 · Cited by 1,135
Self-citationHidalgo, A., Chang, J., Jang, J.-E., Peired, A. J., Chiang, E. Y., & Frenette, P. S. (2009) · Nature Medicine · doi:10.1038/nm.1939 · Cited by 358
Self-citationInfection in sickle cell disease: A review
Booth, C., Inusa, B., & Obaro, S. K. (2010) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2009.03.010 · Cited by 357
Sickle Cell Disease—Genetics, Pathophysiology, Clinical Presentation and Treatment
Inusa, B., Hsu, L., Kohli, N., Patel, A., Ominu-Evbota, K., Anie, K., & Atoyebi, W. (2019) · International Journal of Neonatal Screening · doi:10.3390/ijns5020020 · Cited by 313
Barabino, G. A., Platt, M. O., & Kaul, D. K. (2010) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-070909-105339 · Cited by 311
Steinberg, M. H. (2008) · The Scientific World JOURNAL · doi:10.1100/tsw.2008.157 · Cited by 293
Treating sickle cell disease by targeting HbS polymerization
Eaton, W. A., & Bunn, H. F. (2017) · Blood · doi:10.1182/blood-2017-02-765891 · Cited by 255
GMI-1070, a novel pan-selectin antagonist, reverses acute vascular occlusions in sickle cell mice
Chang, J., Patton, J. T., Sarkar, A., Ernst, B., Magnani, J. L., & Frenette, P. S. (2010) · Blood · doi:10.1182/blood-2009-12-260513 · Cited by 238
Self-citationManagement of sickle cell disease from childhood through adulthood
Kanter, J., & Kruse-Jarres, R. (2013) · Blood Reviews · doi:10.1016/j.blre.2013.09.001 · Cited by 182
Mannino, R. G., Myers, D. R., Ahn, B., Wang, Y., Rollins, M., Gole, H., Lin, A. S., Guldberg, R. E., Giddens, D. P., Timmins, L. H., et al. (2015) · Scientific Reports · doi:10.1038/srep12401 · Cited by 127
Phase 1 Study of the E-Selectin Inhibitor GMI 1070 in Patients with Sickle Cell Anemia
Wun, T., Styles, L., DeCastro, L., Telen, M. J., Kuypers, F., Cheung, A., Kramer, W., Flanner, H., Rhee, S., Magnani, J. L., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101301 · Cited by 69
Dean, J. G. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00232 · Cited by 37
Metadata
- Authors
- Frenette, P. S., & Atweh, G. F.
- Venue
- Journal of Clinical Investigation
- Published
- 2007-04-02
- Volume
- 117
- Issue
- 4
- Pages
- 850-858
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2035494124
- Cited by
- 400
- References
- 129
- FWCI
- 10.01
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.